A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease

  • Manners, David (Investigator 01)

Project Details

StatusActive
Effective start/end date1/10/24 → 30/09/26

Funding

  • PPD PTY LTD: A$45,000.00